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Introduction
In addition to the morbidity and mortal-
ity caused by opportunistic infections 
that we discussed in the two previous 
articles, a number other conditions 
are also associated with HIV-infection. 
These HIV-associated conditions may 
have  devastating consequences; in 
this article we discuss some of the most 
common and severe conditions accord-
ing to the main system affected.   
Neurological conditions  
HIV encephalopathy 
HIV encephalopathy is the most com-
mon neurological manifestation of HIV in 
children and may be a presenting fea-
ture. The diagnosis is mainly made on 
clinical grounds. Regular measurement 
and charting of the head circumference 
in the first 3 years of life and careful as-
sessment of the neuro developmental 
progress is an important part of the 
management of all HIV-infected chil-
dren. Feeding difficulty, especially na-
sopharyngeal incoordination, may be an 
important pointer to neurological illness 
and may lead to other co-morbidities 
such as malnutrition and/or aspiration 
with chronic lung disease. 
The American Academy of Neurology 
AIDS Task force defined HIV encepha-
lopathy as: 
At least one of the following progressive 
findings present for at least two months 
in the absence of a concurrent illness 
other than HIV-infection that could ex-
plain the findings.  
1.  Acquired microcephaly as dem-
onstrated by head circumference 
measurement or brain atrophy on 
serial computed tomography (CT) or 
magnetic resonance imaging (MRI) 
imaging in children younger than 2 
years of age.
2.  Acquired symmetrical motor deficits 
manifested by two or more of the fol-
lowing: paresis, pathological reflexes, 
ataxia or gait disturbance.
3.  Failure to attain or loss of develop-
mental milestones or loss of intel-
lectual ability verified by standard 
developmental or neuropsychologi-
cal tests.
Lumbar puncture (LP) is only required 
if a central nervous system (CNS) infec-
tion is suspected and neuroimaging, al-
though mentioned in the case definition, 
is not required to establish the diagno-
sis. Neuroradiological changes usually 
lag behind clinical findings. 
The following features are associated 
with specific special investigations: 
•  Cerebrospinal fluid (CSF) - normal or 
lymphocytic pleocytosis and mildly 
elevated protein 
•  CT-Brain -  global cerebral atrophy 
and basal ganglia calcifications 
•  MRI-Brain - diffuse white matter 
changes. 
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HIV related encephalopathy is a WHO 
Stage IV condition, mandating highly 
active antiretroviral therapy regardless 
of the CD4 count or percent.1-3 Support-
ive physiotherapy, occupational therapy 
and speech therapy may be required. 
It is important to inform caretakers that 
although some functional improvement 
should occur, this may not be up to the 
age related norm. Table 1 illustrates the 
various clinical courses in the absence 
of HAART. Timely initiation of HAART will 
significantly reduce the development of 
HIV encephalopathy. 
HIV-infected children are also at 
risk of other developmental and neu-
ropsychiatric problems besides HIV 
encephalopathy.  These conditions 
are summarized in table 2 and should 
be managed as in HIV-uninfected chil-
dren; expert help should be sought as 
indicated.4
Seizures
Seizures are not usually associated with 
HIV related CNS disease, as HIV af-
fects mostly the white matter. However, 
simple febrile seizures may occur.  The 
indications for lumbar puncture and im-
aging are as for HIV-uninfected children 
and if seizures do occur, standard anti-
convulsants usually result in satisfactory 
control. There may be significant drug 
interactions between anticonvulsants 
(carbamazepine in particular) and anti-
retroviral drugs, which may cause drug-
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Table I: Various clinical courses described for children with HIV encephalopathy
Type Course
Static Developmental arrest (No loss or gain of milestones)
Progressive 
Acute Rapid and relentless pro-gression
Plateau Indolent, slow progression

















Behavioral Often detected in older children





Expressive language deficit 
Learning disabilities
Cognitive scores below childhood norm
related toxicity and/or reduced efficacy. 
Most experts recommend that carbam-
azepine should be avoided in HIV-in-
fected children on anti-retroviral therapy 
(ARVs), as it may induce leucopenia. 
Therapeutic drug monitoring should be 
considered to ensure adequate levels of 
both the anticonvulsants and ARVs.
Pulmonary conditions
Lung disease in children with HIV may 
have complex etiology, not only related 
to infections as previously discussed.5 
Lymphoid Interstitial Pneumonia
Lymphoid Interstitial Pneumonia (LIP) 
represents 25 - 40% of the pulmonary 
disease burden in HIV infected children. 
The natural history of LIP seems variable 
and is not fully understood. It was previ-
ously seen as a relatively benign mani-
festation of HIV, but it may have severe 
consequences such as bronchietasis, 
cor pulmonale and respiratory failure. 
Pulmonary findings suggestive of 
LIP include persistent coughing and 
tachypnea, while auscultatory findings 
are rare in the absence of secondary 
pneumonia.  Extrapulmonary findings 
are often most helpful to support the 
diagnosis and include; digital club-
bing, generalized lymphadenopathy, 
hepatosplenomegaly and parotid en-
largement.  The chest radiograph (CXR) 
usually shows bilateral reticulonodular 
interstitial pulmonary infiltrates that per-
sists for more than two months, without 
response to antibiotics or proof of a 
potential pathogen such as tuberculosis 
(TB).1 The lung periphery is often less 
affected and hilar adenopathy may be 
pronounced, but airway compression 
has not been demonstrated.
Due to the chronicity of the symp-
toms and the CXR findings it may be 
challenging to differentiate LIP from 
intra-thoracic TB or bronchiectasis from 
another cause.  It remains debatable 
whether LIP should serve as an indi-
cation to initiate HAART. Current WHO 
guidelines recommend a CD4-based 
approach, but it is the belief of the 
authors that children with LIP together 
with recurrent pneumonia and/or signs 
of progressive illness should receive 
HAART regardless of their CD4 count.3 
Highly active antiretroviral therapy 
(HAART) is the mainstay of treatment. 
Corticosteroids may be used to alleviate 
severe hypoxia, but this should be used 
with caution and only in severe cases 
due to considerable side-effects.
Bronchietasis
Bronchiectasis represents an abnormal 
and irreversible dilatation of the airways 
that disrupts normal airway functioning 
and usually results from severe and/or 
recurrent infections. It is a common 
problem and occurs in up to 16% of chil-
dren with HIV. HIV-infected children are 
vulnerable to develop bronchiectasis for 
a number of reasons: 1) recurrent and/
or severe pulmonary infections result-
ing from impaired cellular and humoral 
immunity, as well as compromised local 
defence mechanisms, 2) LIP and 3) 
neurodevelopmental abnormalities or 
oesophagitis that may lead to repeated 
aspiration.
Productive cough is a common 
symptom. Classically the production of 
copious amounts of purulent sputum is 
described, but young children frequent-
ly swallow their sputum, making this 
a less obvious symptom. Coughing is 
often worse at night, while other classi-
cal signs include clubbing and halitosis. 
Auscultation findings are nonspecific 
with crepitations and/or wheezes. The 
CXR may show a honeycomb appear-
ance (small cysts) and/or persistent ar-
eas of opacification and/or widespread 
lung destruction, usually with fibrosis 
and volume loss. A CT scan of the 
lung is the best diagnostic modality to 
delineate the full extent of involvement. 
Treatment includes home physiotherapy 
and aggressive management of infec-
tion. It is the opinion of the authors that 
all children with bronchiectasis should 
receive HAART regardless of the CD4% 
and surgical removal of an affected 
lobe or segment should be considered 
if symptoms persist despite good HIV 
control.3
Renal disease
Children with HIV are at risk of develo-
ping all the usual renal problems associ-
ated with this population including but 
not limited to acute renal failure due to 
dehydration and hemolytic uremic syn-
drome, in addition many drugs including 
co-trimoxasole may be nephrotoxic.
Glomerulopathy 
The incidence of glomerulopathy in HIV-
infected children in South Africa is un-
certain. Although very few present with 
frank nephrotic syndrome, an audit at 
the Red Cross Children’s Hospital found 
that approximately 15% of pediatric pa-
tients screened had significant asymp-
tomatic proteinuria. (Personal communi-
cation Dr McCullough, Dr Nourse).This 
is similar to the limited reports from other 
countries.
In South African children with renal 
disease who have undergone biopsy 
typical HIV associated glomerulopathy 
(HIVAN) was not found to be the pre-
dominant lesion rather immune complex 
disease, as well as a wide range of other 
lesions. (Personal communication Dr 
*Spastic diparesis - Increased tone and pathological reflexes mainly in the legs
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Nourse) In the era of HAART HIVAN and 
other HIV associated glomerulopathies 
may become a more important clinical 
problem.  
Screening with dipstix should be per-
formed every 6 months and if protein or 
hematuria are detected blood pressure 
should be determined. Remember that 
the urine dipstix may be positive without 
necessarily indicating renal disease 
when fever, intercurrent infections and 
and/or nappy rash are present.
The child should be assessed for 
edema. In the absence of additional 
clinical features children should be 
managed according to the algorithm in 
figure 1. Calculating the protein (mg/dL) 
creatinine (mg/dL)  ratio in a random 
urine specimen have been shown to 
have a high correlation with protein ex-
cretion determinations. Ratios less than 
0.5 in children younger than 2 yr of age 
and less than 0.2 in children 2 yr of age 
or older suggest normal protein excre-
tion. A ratio greater than 3 indicates 
nephrotic-range proteinuria. 
Normal creatinine values are age-
dependant. The formula for calculating 
glomerular filtration rate and the age re-
lated normal values are given in table 3.
These children should be managed 
with support from a pediatric nephrolo-
gist or experienced pediatrician.6-8
Management guidelines include the fol-
lowing: 
•  HAART prevents the onset, may slow 
the progression and even induce 
remission. All patients with proven 
glomerulopathies and those with 
proteinuria should receive HAART. 
Unfortunately glomerulopathies other 
than HIVAN may have a less favor-
able response. In children with es-
tablished renal failure the dosages of 
drugs needs to be adopted accord-
ing to the glomerular filtration rate.
•  ACE inhibitors should be started in 
children with more than 1g/l of pro-
teinuria. Caution should be exercised 
in children with suspected salt-losing 
nephropathy. Discontinue temporar-
ily in the presence of dehydrating di-
arrhea as acute tubular necrosis may 
be precipitated. As these drugs may 
be teratogenic girls of child-bearing 
age should use birth control.
•  Corticosteroids and cyclosporin may 
benefit some children but should not 
be used without expert advice.
Urinary tract infections
Like in HIV-negative children clinicians 
should suspect urinary tract infection in 
any child with a febrile illness with out a 
detectable focus of infection. The man-
Figure 1: Assessment of proteinuria
1+ Protein OR1+blood
(If nappy rash, may need a catheter or suprapubic specimen;
alternatively repeat dipstix once resolved)




Send random urine sample
for protein/creatinine ratio*
Abnormal Normal
Refer to tertiary center
Treat and investigate
as for urinary tract
infection
Repeat dipstix Wait 3-6
Months
*<2 Years < 0.5
>2 Years < 0.2
Ratio > 3 Suggests nephrotic range
agement of these patients are similar 
to HIV-negative children. Children <1yr 
of age with a confirmed urinary tract 
infection should be investigated with a 
renal ultrasound and a micturating cys-
togram. Children >1 year should have a 
renal ultrasound and further investiga-




The new WHO clinical staging classi-
fies dilated cardiomiopathy as a stage 
4 disease, due to the high morbidity and 
mortality associated with this condition. 
Management includes standard antifail-
ure therapy, such as diuretics and low 
dose ACE inhibitors; digoxin is rarely 
indicated. Because it is recognized as 
a stage 4 disease, initiation of antiretro-
viral therapy is indicated regardless of 
Table 3: Schwartz formula and age related normal value of creatinine and glomerular filtration 
rate 




Schwartz formula : GFR (µmol/L)=k x height (cm) x Creatinine (µmol/L)
Preterm Infant k=29
Infants < 1 year k=40
Children 1-13 years k=49
the CD4 count. 
Cor pulmonale
Right heart failure may occur as a result 
of chronic lung disease or airway ob-
struction. The diagnosis is mainly made 
on clinical grounds with signs of right 
ventricular hypertrophy.  If available, 
CXR, ECG and/or echocardiography 
findings may provide confirmation. 
Management includes treating the un-
derlying cause if possible and providing 
optimal supportive care. 
Conditions of the gastro intestinal tract
HIV associated failure to thrive 
Failure of an HIV-infected child to gain 
weight may have multiple causes.  Poor 
food security, poor nutrition choices and 
infections of the gastrointestinal tract 
or chronic diseases such as TB may 
all contribute. Gastrointestinal infec-
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tions may lead to anorexia, dysphagia, 
malabsorption and/or protein losing en-
teropathy.  An attempt should be made 
to make a definitive diagnosis and to ad-
dress the underlying problem as growth 
failure is an important component of the 
staging process.1  In addition to the 
contribution of opportunistic infections, 
HIV-infection itself may cause loss of ap-
petite, malabsorption and an increased 
metabolic rate.  
A good history should be taken fo-
cusing on the diet, swallowing disorders, 
other intestinal complaints (diarrhoea 
and abdominal pain), and symptoms 
of systemic disease. The dietary his-
tory should include details of the type, 
frequency, and amount of food the in-
fant receives. Weight, length, weight for 
length, and growth rate should be evalu-
ated. A full clinical assessment should 
be performed and special investigations 
requested as indicated.
All children should be dewormed 
regularly (every 6 months), while food 
security and the need for supplementa-
tion should be assessed. If significant 
growth failure persists despite regular 
deworming, the provision of adequate 
food and additional supplements as 
needed (especially iron), and after 
chronic diseases such as TB have been 
excluded; then HAART initiation should 
be considered.
Swallowing disorders and reflux
The prevalence of swallowing disorders 
and gastro-oesophageal reflux disease 
(GORD) among HIV-infected children 
is poorly quantified, but is frequently 
encountered in clinical practice.  Swal-
lowing disorders may contribute sig-
nificantly to morbidity in HIV-infected 
infants.  Coughing and/or milk pouring 
through the nose whilst feeding is sug-
gestive of poorly coordinated swallow-
ing, which is a particular problem in chil-
dren with encephalopathy. GORD may 
be indicated by a history of regurgitating 
small quantities of feed and/or coughing 
that follows soon after a feed.  
The diagnosis of GORD and its asso-
ciated complications remains challeng-
ing. Oesophagoscopy with biopsy is 
the investigation of choice to establish a 
definitive diagnosis of oesophagitis, but 
this is rarely available. A barium swallow 
may show irregularity of the oesopha-
geal mucosa or even strictures in the 
presence of oesophagitis, while active 
swallowing may be evaluated simulta-
neously. A therapeutic trial with proton 
pump inhibitors, trans-pyloric feeds 
and/or careful observation of the patient 
while feeding may be required to estab-
lish a diagnosis with some confidence.
Omeprazole is the treatment of choice 
for reflux oesophagitis and acid related 
upper and lower airway disease.9 How-
ever, many airway complications are not 
acid related; the value of proton pump 
blockers in the management of these is 
uncertain and stomach acid fulfills an 
important protective function against 
common gastro-intestinal pathogens. 
Conservative measures such as avoid-
ing feeds of excessive volume, correct 
feeding technique and positioning of the 
infant during and after feeds are often 
useful. Children with persistent severe 
symptoms not responding to conserva-
tive measures and/or medical therapy 
should be evaluated for a surgical anti-
reflux procedure.
Uncoordinated swallowing is even 
more challenging to manage. The assis-
tance of a speech therapist is invaluable 
in this situation. Strategies such as ma-
nipulating the consistency of feeds and 
appropriate feeding technique frequent-
ly control the symptoms. Some children 
may require naso-gastric feeding by 
tube (infants with respiratory distress 
should receive an oro-gastric tube), but 
this should only be considered for short 
term management or in severe cases. 
The infant’s caretakers should be 
counseled and assisted with switching 
to solid food safely and with the use of 
cup feeds. In very severe cases, where 
no progress is made, a gastrostomy 
may be the only long term option. When 
this condition is due to HIV-associated 
neurodevelopmental delay then HAART 
may improve the problem.
Haematological conditions
Hematological abnormalities are com-
mon in HIV-infected children. When 
more that one cell type is persistently 




penia is also fairly common and may be 
problematic to treat. Children with plate-
let counts > 30 000 µl/microL seldom 
have serious bleeds. Like with other 
forms of idiopathic thrombocytomenic 
purpera the management is much dis-
cussed. Although the use of corticoste-
roid and/or intravenous immunoglobulin 
(IVIG) is widely advocated, these 
modalities have not been studied in a 
controlled fashion. Various doses and 
durations of treatment are mentioned in 
the literature. In situations where a rapid 
increase of the platelet count is desir-
able (ie acute severe bleeding) IVIG 
may have an advantage over steroids.10 
Prolonged courses of steroids in chil-
dren that show no response should not 
be given. Recurrent severe bleeding is 
an indication to initiate HAART, regard-
less of the CD4 count.3
Anemia
Anemia is extremely common, but be-
fore ascribing the anemia to HIV, com-
mon causes such as malnutrition, iron 
deficiency and chronic infections should 
be excluded. In addition antiretroviral 
drugs, zidovudine (AZT) in particular, 
may cause anemia. A positive Coombs 
test reflects the presence of immune 
mediated haemolysis, this may have 
many causes for example various viral 
or bacterial infections, the use of antibi-
otics or other drugs and it may also be a 
HIV related phenomenon.
Conclusion
This article is the last in our series of 6 
articles that discussed the management 
of HIV-infected children.  The full series 
is available on-line at SAFP website 
(www.safpj.co.za) and should assist 
clinicians to provide optimal care to HIV-
infected infants and children
  The second edition of the Southern 
African Handbook of HIV medicine is 
currently under review and clinicians 
are encouraged to consult this as a 
supplementary text.  Thank you for car-
ing about HIV-infected children, we trust 
that you will find it as interesting, frustrat-
ing and rewarding as we do.
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